However, using serum or plasma levels of BDNF as a biomarker presents challenges due to the release of BDNF from human blood platelets [177,178], leading to varied results in studies analyzing BDNF levels in schizophrenia patients [165,179]. This evidence concerns the gene BDNF and schizophrenia.